Losing Your Hair? It’s Simpler (and Faster) to Regrow Than You Think
Regrow your hair in as few as 3-6 months* with Hims.
Welcome to Talking Points, a series that looks at what makes certain products worth talking about, brought to you by Gear Patrol Studios.
Note: All content in this article is based on information provided or published by Hims. Gear Patrol has not itself tested or evaluated the products or statements about them. Readers should consult with their physician or medical professional before using any drug.
Losing your hair is an incredibly personal experience. But it’s also incredibly common: two out of every three men will have experienced some degree of hair loss by age 35, according to the American Hair Loss Association.
The good news is that hair loss can be treatable, and with treatment through Hims, it’s never been simpler to get effective care. Here’s how it works.
HimsGetting started could not be more simple.
The process takes place 100 percent online, and you don’t need insurance to participate. Just answer a few simple questions, and a licensed medical provider will determine if a prescription is right for you.
If prescribed, the vetted provider will develop a personalized treatment plan to fit your needs, and medications will ship directly to you. Hims Hair subscribers also receive complete support throughout the process, including unlimited check-ins and messaging with the care team.
Hims offers a range of options to stop hair loss and regrow hair.
Whether you’re just beginning to notice thinning or you’ve been experiencing hair loss for some time, Hims offers access to a range of effective products that can help.
Products combine trusted and effective ingredients, like finasteride and minoxidil, Dermatologist-recommended prescription ingredients shown to regrow hair in as little as 3-6 months*. In addition to being fast-acting, finasteride and minoxidil have been shown to be highly effective. Among those using products with finasteride, 90% saw reduced hair loss or increased regrowth using finasteride** and four in five minoxidil users experienced significant improvement in hair loss***.
Hims offers these efficacious products in a variety of delivery formats, including a topical spray (Hims’s #1 customer favorite), a citrus flavored chewable, and a dropper-applied topical serum. Regardless of which product is prescribed to you, rest assured that the treatment is as simple as the onboarding process — each of the aforementioned products only need to be taken or applied once daily.
Effective hair loss treatment has never been more convenient or accessible.
Hair loss can feel like an inevitable experience for affected men. Hims is on a mission to show them that it’s anything but inevitable and that it can be treated effectively without costly and time-consuming in-person appointments.
The brand’s innovative, personalized, internet-based approach eliminates the most common blockers preventing men from accessing the support of medical professionals needed to stop or reverse hair loss.
So, if you’re affected by hair loss and haven’t been sure what your options are, Hims is here to help.
Legal Disclaimer: Hair Hybrids are compounded products and have not been approved by the FDA. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. Restrictions apply. See website for full details and important safety information.
*Based on separate individual studies of oral minoxidil and oral finasteride.
**Source: Kaufman, KD et al. “Finasteride in the treatment of men with androgenetic alopecia.” J. of the American Academy of Dermatology. Based on two 1-year clinical trials, where 1553 men (18 to 41 years of age) with male pattern hair loss received oral finasteride 1 mg/d or placebo, and 1215 men continued in blinded extension studies for a second year. .
***Source: Beach, Renée A. et al. “Low-dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series” J. of the American Academy of Dermatology.
Source: www.gearpatrol.com
